This topic contains a solution. Click here to go to the answer

Author Question: Potential causes for respiratory alkalosis include 1. hypotension. 2. hypertension. 3. ... (Read 73 times)

melina_rosy

  • Hero Member
  • *****
  • Posts: 531
Potential causes for respiratory alkalosis include
 
  1. hypotension.
  2. hypertension.
  3. hypoventilation.
  4. hyperventilation.

Question 2

Electrolytes are essential for many body functions, and require a
 
  1. wide level range.
  2. low level range.
  3. narrow level range.
  4. high level range.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

aham8f

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

Correct Answer: 4
Rationale 1: Hypotension is unrelated.
Rationale 2: Hypertension is unrelated.
Rationale 3: Hypoventilation is associated with respiratory acidosis.
Rationale 4: Hyperventilation occurs with respiratory alkalosis.

Answer to Question 2

Correct Answer: 3
Rationale: Levels of electrolytes are maintained within a very narrow range.




melina_rosy

  • Member
  • Posts: 531
Reply 2 on: Jul 23, 2018
Thanks for the timely response, appreciate it


xiazhe

  • Member
  • Posts: 331
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Adolescents often feel clumsy during puberty because during this time of development, their hands and feet grow faster than their arms and legs do. The body is therefore out of proportion. One out of five adolescents actually experiences growing pains during this period.

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

Persons who overdose with cardiac glycosides have a better chance of overall survival if they can survive the first 24 hours after the overdose.

Did you know?

The most common childhood diseases include croup, chickenpox, ear infections, flu, pneumonia, ringworm, respiratory syncytial virus, scabies, head lice, and asthma.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library